Incorporation of guanethidine into isolated rat peritoneal mast cells and mast cell granules in vitro.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D002021:Buffers; D002122:Calcium Chloride / Q000494:pharmacology; D003594:Cytoplasmic Granules / Q000187:drug effects; D005260:Female; D006145:Guanethidine / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism*; D010537:Peritoneum / Q000166:cytology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D013696:Temperature; D013997:Time Factors
D000928:Antidepressive Agents; D002021:Buffers; D012701:Serotonin; D012110:Reserpine; D006916:5-Hydroxytryptophan; D008274:Magnesium; D002122:Calcium Chloride; D006145:Guanethidine